Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Baron

Showing results (1-10 of 192) with videos related to

Pageof 20
Sort By:
Nature Medicine|May 4, 2004
Arming the osteoclastRoland Baron
Cell Metabolism|May 9, 2006
FSH versus estrogen: who's guilty of breaking bones?Roland Baron
Nature Reviews. Endocrinology|December 7, 2011
Osteoporosis in 2011: Osteoporosis therapy--dawn of the post-bisphosphonate eraRoland Baron
The Journal of Clinical Endocrinology and Metabolism|January 13, 2012
Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectivesRoland Baron, Eric Hesse
Science Signaling|July 3, 2008
p53 brings a new twist to the Smad signaling networkAzeddine Atfi, Roland Baron
Current Osteoporosis Reports|May 25, 2007
Wnt signaling and the regulation of bone massRoland Baron, Georges Rawadi
Nature Medicine|February 8, 2013
WNT signaling in bone homeostasis and disease: from human mutations to treatmentsRoland Baron, Michaela Kneissel
Reviews in Endocrine & Metabolic Disorders|September 5, 2006
Molecular regulation of osteoclast activityAngela Bruzzaniti, Roland Baron
European Journal of Pharmacology|August 15, 2002
In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiationRoland Baron, Yannis Tsouderos
Current Opinion in Pharmacology|May 13, 2018
Targeting WNT signaling in the treatment of osteoporosisRoland Baron, Francesca Gori
Pageof 20

Showing results (1-10 of 192) with videos related to

Sort By:
Pageof 20
Nature Medicine|May 4, 2004
Arming the osteoclastRoland Baron
Cell Metabolism|May 9, 2006
FSH versus estrogen: who's guilty of breaking bones?Roland Baron
Nature Reviews. Endocrinology|December 7, 2011
Osteoporosis in 2011: Osteoporosis therapy--dawn of the post-bisphosphonate eraRoland Baron
The Journal of Clinical Endocrinology and Metabolism|January 13, 2012
Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectivesRoland Baron, Eric Hesse
Science Signaling|July 3, 2008
p53 brings a new twist to the Smad signaling networkAzeddine Atfi, Roland Baron
Current Osteoporosis Reports|May 25, 2007
Wnt signaling and the regulation of bone massRoland Baron, Georges Rawadi
Nature Medicine|February 8, 2013
WNT signaling in bone homeostasis and disease: from human mutations to treatmentsRoland Baron, Michaela Kneissel
Reviews in Endocrine & Metabolic Disorders|September 5, 2006
Molecular regulation of osteoclast activityAngela Bruzzaniti, Roland Baron
European Journal of Pharmacology|August 15, 2002
In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiationRoland Baron, Yannis Tsouderos
Current Opinion in Pharmacology|May 13, 2018
Targeting WNT signaling in the treatment of osteoporosisRoland Baron, Francesca Gori
Pageof 20